Study: Polypill linked to lower risk of heart disease

01/18/2013 | Capital Times (Madison, Wis.), The

A polypill that includes aspirin, a statin and three blood pressure lowering drugs could lower the lifetime risk of heart disease by 21% in men and 15% in women, a study in Latin America found. The polypill "would be cost-effective and could also be cost-saving," study leader Leonelo Bautista said. The study was published in the journal Health Affairs.

View Full Article in:

Capital Times (Madison, Wis.), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL